Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

This study has been completed.
Sponsor:
Information provided by:
Sanwa Kagaku Kenkyusho Co., Ltd.
ClinicalTrials.gov Identifier:
NCT00334503
First received: June 5, 2006
Last updated: October 8, 2008
Last verified: October 2008

June 5, 2006
October 8, 2008
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00334503 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
Not Provided

The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.

Not Provided
Interventional
Phase 3
Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Type 2 Diabetes Mellitus
Drug: Miglitol
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Type 2 diabetic patients with Biguanide treatment
  • Criteria for postprandial plasma glucose and HbA1c are met

Exclusion Criteria:

  • Type 1 diabetes
  • Patients treated with other antidiabetic drugs or Insulin
Both
20 Years to 69 Years
No
Contact information is only displayed when the study is recruiting subjects
Japan
 
NCT00334503
MG1009
Not Provided
Not Provided
Sanwa Kagaku Kenkyusho Co., Ltd.
Not Provided
Study Director: Clinical Study Group, Clinical Development Dept. Sanwa Kagaku Kenkyusho Co., Ltd.
Sanwa Kagaku Kenkyusho Co., Ltd.
October 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP